LT2004018A - Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms - Google Patents

Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

Info

Publication number
LT2004018A
LT2004018A LT2004018A LT2004018A LT2004018A LT 2004018 A LT2004018 A LT 2004018A LT 2004018 A LT2004018 A LT 2004018A LT 2004018 A LT2004018 A LT 2004018A LT 2004018 A LT2004018 A LT 2004018A
Authority
LT
Lithuania
Prior art keywords
processes
forms
novel
preparation
preparing
Prior art date
Application number
LT2004018A
Other languages
Lithuanian (lt)
Other versions
LT5196B (en
Inventor
Judith Aronhime
Rami Lidor-Hadas
Valerie Niddam-Hildesheim
Revital Lifshitz-Liron
Eti Kovalevski-Ishai
Guy Samburski
Original Assignee
Teva Pharmaceutical Industries Ltd., ,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd., , filed Critical Teva Pharmaceutical Industries Ltd., ,
Publication of LT2004018A publication Critical patent/LT2004018A/en
Publication of LT5196B publication Critical patent/LT5196B/en

Links

Landscapes

  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides novel forms of atorvastatin designated Forms VI, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II, IV, V and amorphous atorvastatin.
LT2004018A 2000-11-30 2004-02-13 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms LT5196B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25007200P 2000-11-30 2000-11-30
US32652901P 2001-10-01 2001-10-01

Publications (2)

Publication Number Publication Date
LT2004018A true LT2004018A (en) 2004-09-27
LT5196B LT5196B (en) 2005-02-25

Family

ID=32930065

Family Applications (1)

Application Number Title Priority Date Filing Date
LT2004018A LT5196B (en) 2000-11-30 2004-02-13 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

Country Status (1)

Country Link
LT (1) LT5196B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US31555A (en) 1861-02-26 Improvement in manufacture of spoons
US4681893A (en) 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
FI94339C (en) 1989-07-21 1995-08-25 Warner Lambert Co Process for the preparation of pharmaceutically acceptable [R- (R *, R *)] - 2- (4-fluorophenyl) -, - dihydroxy-5- (1-methylethyl) -3-phenyl-4 - [(phenylamino) carbonyl] -1H- for the preparation of pyrrole-1-heptanoic acid and its pharmaceutically acceptable salts
HRP960313B1 (en) 1995-07-17 2002-08-31 Warner Lambert Co Form iii crystalline (r- (r*, r*)-2- (4-fluorophenyl) -beta-delta-hydroxy-5-(1-methylethyl) -3-phenyl-4- ((phenylamino) carbonyl -1h-pyrrole-1-heptanoic acid calcium salt (2:1)
US5959156A (en) 1998-11-12 1999-09-28 Bp Amoco Corporation Preparation of polyoxymethylene dimethyl ethers by catalytic conversion of dimethyl ether with formaldehyde formed by oxy-dehydrogenation of dimethyl ether

Also Published As

Publication number Publication date
LT5196B (en) 2005-02-25

Similar Documents

Publication Publication Date Title
YU42803A (en) Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
BG101110A (en) Substituted pyrimidine compounds and their application
MXPA03011329A (en) Novel anti-infectives.
TNSN07235A1 (en) Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
MXPA03006093A (en) N(phenylsulphonyl)glycine derivatives and their therapeutic use.
WO2004043918A3 (en) Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
AU2003240517A1 (en) Substituted pyrrolines as kinase inhibitors
IN2012DE00109A (en)
MY133969A (en) Indoloquinazolinones
AU2002353775A1 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
AU7027100A (en) Novel compounds
BG106002A (en) Process for preparing pesticidal intermediates
MXPA03010498A (en) Process for the preparation of imipenem.
MXPA04005151A (en) Therapeutic compounds.
GB0108903D0 (en) Novel crystalline forms of a factor Xa inhibitor
LT2004018A (en) Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
GB9806409D0 (en) Processes for preparing intermediates
IL148161A0 (en) Process for the preparation of 2-cyanopyridines
ZA983231B (en) Substituted benzyloxyimino compounds.
MXPA04000623A (en) Tetrahydropyridazine derivatives and their use as pesticides.
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine
DE60212130D1 (en) Carvedilolpolymorph
MXPA05007696A (en) Crystalline modification of a manganese complex.
WO2004018470A3 (en) Crystalline solid famciclovir forms i, ii, iii and preparation thereof

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20051129